Sequence Permutation Generates Peptides with Different Antimicrobial and Antibiofilm Activities
Open Access
- 25 September 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (10) , 271
Abstract
Antibiotic resistance poses a threat to our society, and 10 million people could die by 2050. To design potent antimicrobials, we made use of the antimicrobial peptide database (APD). Using the database filtering technology, we identified a useful template and converted it into an effective peptide WW291 against methicillin-resistant Staphylococcus aureus (MRSA). Here, we compared the antibacterial activity and cytotoxicity of a family of peptides obtained from sequence permutation of WW291. The resulting eight WW peptides (WW291-WW298) gained different activities against a panel of bacteria. While WW295 inhibited the growth of Escherichia coli, WW298 was highly active against S. aureus USA300 LAC. Consistently with this, WW298 was more effective in permeating or depolarizing the S. aureus membranes, whereas WW295 potently permeated the E. coli membranes. In addition, WW298, but not WW295, inhibited the MRSA attachment and could disrupt its preformed biofilms more effectively than daptomycin. WW298 also protected wax moths Galleria mellonella from MRSA infection causing death. Thus, sequence permutation provides one useful avenue to generating antimicrobial peptides with varying activity spectra. Taken together with amino acid composition modulation, these methods may lead to narrow-spectrum peptides that are more promising to selectively eliminate invading pathogens without damaging commensal microbiota.Keywords
Funding Information
- National Institutes of Health (AI105147, GM138552)
This publication has 48 references indexed in Scilit:
- Database-Guided Discovery of Potent Peptides to Combat HIV-1 or SuperbugsPharmaceuticals, 2013
- Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLETPLOS ONE, 2013
- Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300International Journal of Antimicrobial Agents, 2012
- Designing antimicrobial peptides: form follows functionNature Reviews Drug Discovery, 2011
- Staphylococcus aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In VivoThe Journal of Immunology, 2011
- Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agentsJournal of Antimicrobial Chemotherapy, 2011
- Identification of Novel Human Immunodeficiency Virus Type 1-Inhibitory Peptides Based on the Antimicrobial Peptide DatabaseAntimicrobial Agents and Chemotherapy, 2010
- Anti-Human Immunodeficiency Virus Type 1 Activities of Antimicrobial Peptides Derived from Human and Bovine CathelicidinsAntimicrobial Agents and Chemotherapy, 2008
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.Journal of Clinical Investigation, 1989